2,788
Views
1
CrossRef citations to date
0
Altmetric
Rapid Communication

VERITAS: Harnessing the power of nomenclature in biologic discovery

ORCID Icon, , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Article: 2207232 | Received 09 Jan 2023, Accepted 21 Apr 2023, Published online: 10 May 2023
 

ABSTRACT

We are entering an era in which therapeutic proteins are assembled using building block-like strategies, with no standardized schema to discuss these formats. Existing nomenclatures, like AbML, sacrifice human readability for precision. Therefore, considering even a dozen such formats, in combination with hundreds of possible targets, can create confusion and increase the complexity of drug discovery. To address this challenge, we introduce Verified Taxonomy for Antibodies (VERITAS). This classification and nomenclature scheme is extensible to multispecific therapeutic formats and beyond. VERITAS names are easy to understand while drawing direct connections to the structure of a given format, with or without specific target information, making these names useful to adopt in scientific discourse and as inputs to machine learning algorithms for drug development.

Abbreviations

AbML=

Antibody Markup Language

ADAPTIR=

Aptevo Therapeutics’ bispecific antibody platform

ATTACK=

Asymmetric Tandem Trimerbody for T cell Activation and Cancer Killing

BiTE®=

Bispecific T cell Engager

CD3=

cluster of differentiation 3

CH1=

constant domain 1 of heavy chain

CH2=

constant domain 2 of heavy chain

CH3=

constant domain 3 of heavy chain

CL=

constant domain of light chain

CODV=

cross-over dual variable

CPM=

charge-pair mutation

DART=

Dual Affinity Re-Targeting

DVD-Ig=

dual variable domain immunoglobulin

EGFR=

EGFR – epithelial growth factor receptor

Fab=

fragment antigen binding (composed of VH, CH1, VL, and CL)

Fc=

fragment crystallizable (composed of a dimer of CH1, CH2, and CH3)

Fv=

variable region of antibody (composed of VH and VL)

heteroFc=

heterodimeric Fc

Fd=

fragment difficult (composed of VH and CH1)

HLE=

half-life extended

Ig=

immunoglobulin

IgG=

immunoglobulin G

MsAb=

multispecific antibody

KiH=

knobs-into-holes

LC=

light chain of antibody (composed of VL and CL)

scFab=

single chain Fab

scFv=

single chain Fv

VERITAS=

Verified Taxonomy for Antibodies

VH=

variable domain of heavy chain

VHH=

variable domain of heavy chain only antibody

VL=

variable domain of light chain

Acknowledgments

The authors thank Atipat (Dak) Rojnuckarin for his work in implementing the scheme in Amgen’s internal applications and databases. We also thank Ai Ching Lim for her support in developing VERITAS. Finally, we thank the members of Amgen Biologic Therapeutic Discovery and Process Development for their valuable feedback on the scheme during development.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

All work was funded by Amgen, Inc